Literature DB >> 29378824

Chromosomal instability during neurogenesis in Huntington's disease.

Albert Ruzo1, Gist F Croft1, Jakob J Metzger1,2, Szilvia Galgoczi1, Lauren J Gerber1, Cecilia Pellegrini1, Hanbin Wang1, Maria Fenner1, Stephanie Tse1, Adam Marks1, Corbyn Nchako1, Ali H Brivanlou3.   

Abstract

Huntington's disease (HD) is a fatal neurodegenerative disease caused by expansion of CAG repeats in the Huntingtin gene (HTT). Neither its pathogenic mechanisms nor the normal functions of HTT are well understood. To model HD in humans, we engineered a genetic allelic series of isogenic human embryonic stem cell (hESC) lines with graded increases in CAG repeat length. Neural differentiation of these lines unveiled a novel developmental HD phenotype: the appearance of giant multinucleated telencephalic neurons at an abundance directly proportional to CAG repeat length, generated by a chromosomal instability and failed cytokinesis over multiple rounds of DNA replication. We conclude that disrupted neurogenesis during development is an important, unrecognized aspect of HD pathogenesis. To address the function of normal HTT protein we generated HTT+/- and HTT-/- lines. Surprisingly, the same phenotype emerged in HTT-/- but not HTT+/- lines. We conclude that HD is a developmental disorder characterized by chromosomal instability that impairs neurogenesis, and that HD represents a genetic dominant-negative loss of function, contrary to the prevalent gain-of-toxic-function hypothesis. The consequences of developmental alterations should be considered as a new target for HD therapies.
© 2018. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  CRISPR; Chromosomal instability; DNA damage and repair; Disease modeling; Human embryonic stem cells; Huntington's disease; Neurogenesis

Mesh:

Substances:

Year:  2018        PMID: 29378824     DOI: 10.1242/dev.156844

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  18 in total

Review 1.  The Role of Transposable Elements of the Human Genome in Neuronal Function and Pathology.

Authors:  Ekaterina Chesnokova; Alexander Beletskiy; Peter Kolosov
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

Review 2.  Neurogenesis in aging and age-related neurodegenerative diseases.

Authors:  Luka Culig; Xixia Chu; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2022-04-29       Impact factor: 11.788

Review 3.  Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.

Authors:  Julia Kaye; Terry Reisine; Steven Finkbeiner
Journal:  Fac Rev       Date:  2022-06-28

Review 4.  Juvenile-Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review.

Authors:  Hannah S Bakels; Raymund A C Roos; Willeke M C van Roon-Mom; Susanne T de Bot
Journal:  Mov Disord       Date:  2021-10-12       Impact factor: 9.698

5.  Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models.

Authors:  Nicholas R Franich; Manuela Basso; Emily A André; Joseph Ochaba; Amit Kumar; Soe Thein; Gianna Fote; Marketta Kachemov; Alice L Lau; Sylvia Y Yeung; Alexander Osmand; Scott O Zeitlin; Rajiv R Ratan; Leslie M Thompson; Joan S Steffan
Journal:  J Huntingtons Dis       Date:  2018

6.  Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington's Disease Monkey pluripotent stem cells.

Authors:  Alexandra V Goodnight; Isaac Kremsky; Sujittra Khampang; Yoon Hee Jung; James M Billingsley; Steven E Bosinger; Victor G Corces; Anthony W S Chan
Journal:  Epigenetics Chromatin       Date:  2019-11-13       Impact factor: 4.954

7.  Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation.

Authors:  Charlene Smith-Geater; Sarah J Hernandez; Ryan G Lim; Miriam Adam; Jie Wu; Jennifer T Stocksdale; Brook T Wassie; Maxwell Philip Gold; Keona Q Wang; Ricardo Miramontes; Lexi Kopan; Iliana Orellana; Shona Joy; Paul J Kemp; Nicholas D Allen; Ernest Fraenkel; Leslie M Thompson
Journal:  Stem Cell Reports       Date:  2020-02-27       Impact factor: 7.765

8.  Human Huntington's disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species.

Authors:  Grace C O'Regan; Sahar H Farag; Caroline S Casey; Alison Wood-Kaczmar; Jennifer M Pocock; Sarah J Tabrizi; Ralph Andre
Journal:  J Neuroinflammation       Date:  2021-04-19       Impact factor: 8.322

9.  Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics.

Authors:  Sergey S Akimov; Mali Jiang; Amanda J Kedaigle; Nicolas Arbez; Leonard O Marque; Chelsy R Eddings; Paul T Ranum; Emma Whelan; Anthony Tang; Ronald Wang; Lauren R DeVine; Conover C Talbot; Robert N Cole; Tamara Ratovitski; Beverly L Davidson; Ernest Fraenkel; Christopher A Ross
Journal:  Hum Mol Genet       Date:  2021-11-30       Impact factor: 5.121

Review 10.  Regenerative Approaches in Huntington's Disease: From Mechanistic Insights to Therapeutic Protocols.

Authors:  Jenny Sassone; Elsa Papadimitriou; Dimitra Thomaidou
Journal:  Front Neurosci       Date:  2018-11-02       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.